ACTRN12608000458336招募中1 期
A phase 1 clinical trial of peptide-pulsed monocyte-derived dendritic cell vaccination to expand adoptively transferred CMV-specific cytotoxic T lymphocytes after allogeneic stem cell transplantation
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- All
入选标准
- •Recipient and donor pairs with haemopoietic stem cell transplant
- •Human Leukocyte Antigen (HLA)-A2 positive
- •CMV seropositive donor
- •Fully HLA-matched or one antigen mismatched allogeneic transplant
排除标准
- •HLA-A2 negative or CMV seronegative donor
研究者
相似试验
已完成
1 期
Phase I clinical trial of epitope peptides based vaccines targeting VEGFR1 in patients with advanced renal cell carcinomaadvanced renal cell carcinomaJPRN-UMIN000004911Department of Urology, Kinki University School of Medicine18
已完成
1 期
Phase I clinical trial of epitope peptides based vaccines both targeting RNF43 and VEGFR2 in patients with advanced colorectal cancer.unresectable colorectal cancerJPRN-UMIN000000956Institute of Medical Science The University of Tokyo6
已完成
2 期
Multicenter clinical trial of Percutaneous Peptide Immunization for malignant melanoma patientsmalignant melanomaJPRN-UMIN000005706Hamamatsu University School of Medicine60
已完成
2 期
A phase II clinical trial of personalized peptide vaccination in combination with metformin for castration-resistant prostate cancer (CRPC)Castration-resistant prostate cancerJPRN-UMIN000019879Cancer Vaccine Center, Kurume University School of medicine35
已完成
1 期
Phase 1 & 2 clinical trial using peptide vaccine for VEGFR1 & 2 in combination with S-1 and Cisplatin for patients with advanced gastric cancerunresectable or recurrent gastric cancerJPRN-UMIN000005007Osaka University, Graduate School of Medicine, Department of Gastroenterological Surgery30